Skip to main content

Advertisement

Log in

Decline in hospitalization rates for herpes zoster in Italy (2003–2018): reduction in the burden of disease or changing of hospitalization criteria?

  • Original Article
  • Published:
Aging Clinical and Experimental Research Aims and scope Submit manuscript

Abstract

Background

Herpes Zoster (HZ) is a very demanding disease caused by the reactivation of latent Varicella Zoster Virus. The main aim of this study was to estimate the burden of the HZ hospitalizations in Italy from 2003 to 2018 evaluating temporal trends.

Methods

Retrospective population-based study analyzing Hospital Discharge Records. Hospitalization records reporting the ICD-9 CM 053.X code in the principal diagnosis or in any of the five secondary diagnoses were considered as cases. Trends of hospitalization rates have been evaluated by Joinpoint analyses.

Results

Overall, 99,036 patients were hospitalized with HZ in the 16-year period of the study, and 83,720 (84.5%) of these patients were over 50 years. Hospitalization rate was 10.4 per 100,000 persons/year with a significant decreasing trend from 13.9 in 2003–2006 to 7.8 in 2015–2018 (p < 0.001). Hospitalization rates showed a 20-fold higher risk among subjects aged over 80 years and 11-fold higher risk among 70–79-year-old subjects with respect to those aged less than 50 years. Over time, a statistically significant increase was observed for the case fatality rate (from 1.2 to 1.7%; p < 0.001) and the median length of stay (from 7 to 8 days; p < 0.001).

Conclusions

Zoster is a disease that causes hospitalization as relatively frequent complication and the observed reduced trend over time could be due to a restriction in hospitalization criteria instead of a reduced burden of disease. The decreasing trend should be carefully interpreted, since it could have an impact on promoting herpes zoster vaccination.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Availability of data and materials (data transparency)

Data will be available upon motivated request to the first author.

References

  1. Johnson R, McElhaney J, Pedalino B et al (2007) Prevention of herpes zoster and its painful and debilitating complications. Int J Infect Dis Suppl 2:S43–S48

    Article  Google Scholar 

  2. Johnson RW (2010) Herpes zoster and postherpetic neuralgia. Expert Rev Vaccine 9:21–26

    Article  Google Scholar 

  3. Opstelten W, Zaal MJ (2005) Managing ophthalmic herpes zoster in primary care. BMJ 331:147–151

    Article  Google Scholar 

  4. Cocchio S, Baldovin T, Furlan P et al (2019) Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008–2016. Aging Clin Exp Res 31:145–150

    Article  Google Scholar 

  5. Opstelten W, Mauritz JW, de Wit NJ et al (2002) Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database. Fam Pract 19:471–475

    Article  Google Scholar 

  6. Centers for Disease Control and Prevention (2021) Available at https://www.cdc.gov/shingles/index.html. Accessed 3 Mar 2021

  7. White RR, Lenhart G, Singhal PK et al (2009) Incremental 1-year medical resource utilization and costs for patients with herpes zoster from a set of US health plans. Pharmacoeconomics 27:781–792

    Article  Google Scholar 

  8. Gnann JW Jr (2002) Varicella-zoster virus: atypical presentations and unusual complications. J Infect Dis 186:S91–S98

    Article  Google Scholar 

  9. Lydick E, Epstein RS, Himmelberger D et al (1995) Herpes zoster and quality of life: a self-limited disease with severe impact. Neurology 45:S52–S53

    Article  CAS  Google Scholar 

  10. McElhaney JE (2010) Herpes zoster: a common disease that can have a devastating impact on patients’ quality of life. Expert Rev Vaccines 9:27–30

    Article  Google Scholar 

  11. Gabutti G, Franco E, Bonanni P et al (2015) Reducing the burden of Herpes Zoster in Italy. Hum Vaccin Immunother 11:101–107

    Article  Google Scholar 

  12. Valente N, Cocchio S, Stefanati A et al (2017) Temporal trends in herpes zoster-related hospitalizations in Italy, 2001–2013: differences between regions that have or have not implemented varicella vaccination. Aging Clin Exp Res 29:771–779

    Article  Google Scholar 

  13. Stein AN, Britt H, Harrison C et al (2009) Herpes zoster burden of illness and health care resource utilisation in the Australian population aged 50 years and older. Vaccine 27:520–529

    Article  Google Scholar 

  14. Chidiac C, Bruxelle J, Daures JP et al (2001) Characteristics of patients with herpes zoster on presentation to practitioners in France. Clin Infect Dis 33:62–69

    Article  CAS  Google Scholar 

  15. Brisson M, Edmunds WJ (2003) Epidemiology of Varicella-Zoster Virus in England and Wales. J Med Virol 70:S9–S14

    Article  Google Scholar 

  16. de Melker H, Berbers G, Hahné S et al (2006) The epidemiology of varicella and herpes zoster in The Netherlands: implications for varicella zoster virus vaccination. Vaccine 24:3946–3952

    Article  Google Scholar 

  17. Paul E, Thiel T (1996) Zur Epidemiologie der Varizella-Zoster-Infektion Ergebnisse einer prospektiven Erhebung im Landkreis Ansbach [Epidemiology of varicella zoster infection. Results of a prospective study in the Ansbach area]. Hautarzt 47:604–609

    Article  CAS  Google Scholar 

  18. Gialloreti LE, Merito M, Pezzotti P et al (2010) Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study. BMC Infect Dis 10:230

    Article  Google Scholar 

  19. La scheda di dimissione ospedaliera (SDO). www.salute.gov.it. [Online] http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=1232&area=ricoveriOspedalieri&menu=vuoto. Accessed 3 Nov 2020

  20. ISTAT. Available at http://demo.istat.it/. Accessed 03 Nov 2019

  21. Hobbelen PH, Stowe J, Amirthalingam G et al (2016) The Burden of Hospitalisation for Varicella and Herpes Zoster in England from 2004 to 2013. J Infect 73:241–253

    Article  Google Scholar 

  22. Ultsch B, Siedler A, Rieck T et al (2011) Herpes zoster in Germany: quantifying the burden of disease. BMC Infect Dis 11:173

    Article  Google Scholar 

  23. Schmidt SAJ, Kahlert J, Vestergaard M et al (2016) Hospital-based herpes zoster diagnoses in Denmark: rate, patient characteristics, and all-cause mortality. BMC Infect Dis 16:99

    Article  Google Scholar 

  24. Gil A, Gil R, Alvaro A et al (2009) Burden of Herpes Zoster Requiring Hospitalization in Spain during a Seven-Year Period (1998–2004). BMC Infect Dis 9:55. https://doi.org/10.1186/1471

    Article  PubMed  PubMed Central  Google Scholar 

  25. Kawai K, Gebremeskel BG, Acosta CJ (2014) systematic review of incidence and complications of herpes zoster: towards a global perspective. BMJ Open 4:e004833. https://doi.org/10.1136/bmjopen-2014-004833

    Article  PubMed  PubMed Central  Google Scholar 

  26. Di Legami V, Gianino MM, Ciofi degli Atti M et al (2007) Epidemiology and costs of herpes zoster: background data to estimate the impact of vaccination. Vaccine 25:7598–7604. https://doi.org/10.1016/j.vaccine.2007.07.049

    Article  PubMed  Google Scholar 

  27. Salleras L, Salleras M, Salvador P et al (2015) Herpes zoster and postherpetic neuralgia in Catalonia (Spain). Hum Vaccin Immunother 11:178–184

    Article  Google Scholar 

  28. Mesquita M, Froes F (2013) Hospital Admissions for Herpes Zoster in Portugal between 2000 and 2010. Acta Med Port 26:531–536

    Article  Google Scholar 

  29. Italian Health Ministry. Available at http://www.salute.gov.it/portale/temi/p2_6.jsp?lingua=italiano&id=5458&area=ricoveriOspedalieri&menu=vuoto. Accessed 20 Feb 2020. Last Accessed 21 Jan 2021

  30. Pecoraro F, Clemente F, Luzi D (2020) The efficiency in the ordinary hospital bed management in Italy: an in-depth analysis of intensive care unit in the areas affected by COVID-19 before the outbreak. PLoS ONE 15:e0239249

    Article  CAS  Google Scholar 

  31. Marino D, Quattrone G (2019) A proposal for a new index to evaluate hospital resource allocation: the case of Italian NHS rationalisation. Eur Res Manag Bus Econ 25:23–29. https://doi.org/10.1016/j.iedeen.2018.10.001

    Article  Google Scholar 

  32. Brisson M, Edmunds WJ, Gay NJ et al (2000) Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiol Infect 125:651–669

    Article  CAS  Google Scholar 

  33. Amodio E, Casuccio A, Tramuto F et al (2020) Varicella vaccination as useful strategy for reducing the risk of varicella-related hospitalizations in both vaccinated and unvaccinated cohorts (Italy, 2003–2018). Vaccine 38:5601–5606

    Article  Google Scholar 

  34. Holl K, Sauboin C, Amodio E et al (2016) Coverage, efficacy or dosing interval: Which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy. BMC Public Health 16:1103

    Article  Google Scholar 

  35. Amodio E, Tramuto F, Cracchiolo M et al (2015) The impact of ten years of infant universal Varicella vaccination in Sicily, Italy (2003–2012). Hum Vaccin Immunother 11:236–239

    Article  Google Scholar 

Download references

Acknowledgements

The Authors are fully obliged the Italian Ministry of Health that collected and provided hospitalization data.

Funding

No funding.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Emanuele Amodio.

Ethics declarations

Conflict of interest

Authors do not have competing interests or conflict of interest to declare.

Ethical approval

An ethical approval is not formally required in Italy, since the study analyzes anonymous data collected by the Italian Health Minister.

Informed consent

According to the Italian Law, an informed consent was not required for this study as data were anonymous and collection was retrospective.

Consent to participate

Not required according to the Italian law.

Consent for publication

Not required according to the Italian law.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amodio, E., Marrella, A., Casuccio, A. et al. Decline in hospitalization rates for herpes zoster in Italy (2003–2018): reduction in the burden of disease or changing of hospitalization criteria?. Aging Clin Exp Res 34, 881–886 (2022). https://doi.org/10.1007/s40520-021-02014-7

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40520-021-02014-7

Keywords

Navigation